Literature Citations
1. Design, Synthesis and Antimycobacterial Evaluation of Novel Adamantane and Adamantanol Analogues Effective against Drug-resistant Tuberculosis. Alsayed, S.S.R., S. Lun, A. Payne, W.R. Bishai, and H. Gunosewoyo. Bioorganic Chemistry, 2021. 106: 104486. PMID[33276981]. PMCID[PMC7775894].
[PubMed]. TB_01_2021.
2. Inhibition of Mycobacterium tuberculosis InhA: Design, Synthesis and Evaluation of New di-Triclosan Derivatives. Armstrong, T., M. Lamont, A. Lanne, L.J. Alderwick, and N.R. Thomas. Bioorganic & Medicinal Chemistry, 2020. 28(22): 115744. PMID[33007556].
[PubMed]. TB_01_2021.
3. Synthesis and Antimicrobial Evaluation of New Nitric oxide-donating Fluoroquinolone/Oxime Hybrids. Aziz, H.A., G.A.I. Moustafa, G.E.A. Abuo-Rahma, S.M. Rabea, G. Hauk, V.S. Krishna, D. Sriram, J.M. Berger, and S.H. Abbas. Archiv der Pharmazie, 2021. 354(1): e2000180. PMID[32959443].
[PubMed]. TB_01_2021.
4. Targeted Isolation of Asperheptatides from a Coral-derived Fungus Using LC-MS/MS-Based Molecular Networking and Antitubercular Activities of Modified Cinnamate Derivatives. Chao, R., X.M. Hou, W.F. Xu, Y. Hai, M.Y. Wei, C.Y. Wang, Y.C. Gu, and C.L. Shao. Journal of Natural Products, 2021. 84(1): p. 11-19. PMID[33356261].
[PubMed]. TB_01_2021.
5. Identification of Fusarielin M as a Novel Inhibitor of Mycobacterium tuberculosis Protein Tyrosine phosphatase B (MptpB). Chen, D., L. Liu, Y. Lu, and S. Chen. Bioorganic Chemistry, 2021. 106: p. 104495. PMID[33293055].
[PubMed]. TB_01_2021.
6. Antibacterial Activity of New Substituted 4-N-Alkylated-2-trifluoromethylquinoline Analogues against Sensitive and Resistant Mycobacterium tuberculosis Strains. da Silva, E.T., G.F. de Andrade, A.D. Araujo, M.C.S. Lourenco, and M.V.N. de Souza. European Journal of Pharmaceutical Sciences, 2021. 157: 105596. PMID[33069867].
[PubMed]. TB_01_2021.
7. Evaluation and Docking Study of Pyrazine Containing 1, 3, 4-Oxadiazoles Clubbed with Substituted Azetidin-2-one: A New Class of Potential Antimicrobial and Antitubercular. Das, R. and D.K. Mehta. Drug Research, 2021. 71(1): p. 26-35. PMID[33027823].
[PubMed]. TB_01_2021.
8. Development of Novel Isatin-Nicotinohydrazide Hybrids with Potent Activity against Susceptible/Resistant Mycobacterium tuberculosis and Bronchitis Causing-bacteria. Elsayed, Z.M., W.M. Eldehna, M.M. Abdel-Aziz, M.A. El Hassab, E.B. Elkaeed, T. Al-Warhi, H.A. Abdel-Aziz, S.M. Abou-Seri, and E.R. Mohammed. Journal of Enzyme Inhibition and Medicinal Chemistry, 2021. 36(1): p. 384-393. PMID[33406941]. PMCID[PMC7801109].
[PubMed]. TB_01_2021.
9. Chemical Composition, Antimicrobial, and Lipase Enzyme Activity of Essential Oil and Solvent Extracts from Serapias orientalis Subsp. Orientalis. Erik, I., G. Kilic, E. Ozturk, S.A. Karaoglu, and N. Yayli. Turkish Journal of Chemistry, 2020. 44(6): p. 1655-1662. PMID[33488260]. PMCID[PMC7763115].
[PubMed]. TB_01_2021.
10. Novel Peptidomimetic Peptide Deformylase (Pdf) Inhibitors of Mycobacterium tuberculosis. Gokhale, K.M. and V.N. Telvekar. Chemical Biology and Drug Design, 2021. 97(1): p. 148-156. PMID[32745362].
[PubMed]. TB_01_2021.
11. Two-way Regulation of Mmpl3 Expression Identifies and Validates Inhibitors of Mmpl3 Function in Mycobacterium tuberculosis. Grover, S., C.A. Engelhart, E. Pérez-Herrán, W. Li, K.A. Abrahams, K. Papavinasasundaram, J.M. Bean, C.M. Sassetti, A. Mendoza-Losana, G.S. Besra, M. Jackson, and D. Schnappinger. ACS Infectious Diseases, 2021. 7(1): p. 141-152. PMID[33319550]. PMCID[PMC7802072].
[PubMed]. TB_01_2021.
12. Dithiodiketopiperazine Derivatives from Endophytic Fungi Trichoderma harzianum and Epicoccum nigrum. Harwoko, H., G. Daletos, F. Stuhldreier, J. Lee, S. Wesselborg, M. Feldbrügge, W.E.G. Müller, R. Kalscheuer, E. Ancheeva, and P. Proksch. Natural Product Research, 2021. 35(2): p. 257-265. PMID[31210064].
[PubMed]. TB_01_2021.
13. Antimicrobial Activity of IDD-B40 against Drug-resistant Mycobacterium tuberculosis. Islam, M.I., H. Seo, S. Kim, V.S. Sadu, K.I. Lee, and H.Y. Song. Scientific Reports, 2021. 11(1): 740. PMID[33436895]. PMCID[PMC7804135].
[PubMed]. TB_01_2021.
14. 2-((3,5-Dinitrobenzyl)thio)quinazolinones: Potent Antimycobacterial Agents Activated by Deazaflavin (F420)-Dependent Nitroreductase (Ddn). Jian, Y., H.E. Forbes, F. Hulpia, M.D.P. Risseeuw, G. Caljon, H. Munier-Lehmann, H.I.M. Boshoff, and S. Van Calenbergh. Journal of Medicinal Chemistry, 2021. 64(1): p. 440-457. PMID[33347317].
[PubMed]. TB_01_2021.
15. The Introduction of Hydrazone, Hydrazide, or Azepane Moieties to the Triterpenoid Core Enhances an Activity against M. tuberculosis. Kazakova, O.B., N.I. Medvedeva, I.E. Smirnova, T.V. Lopatina, and A.V. Veselovsky. Medicinal Chemistry, 2021. 17(2): p. 134-145. PMID[31939731].
[PubMed]. TB_01_2021.
16. Design and Synthesis of "Chloropicolinate amides and urea Derivatives" as Novel Inhibitors for Mycobacterium tuberculosis. Konduri, S., D. Bhargavi, J. Prashanth, V.S. Krishna, D. Sriram, and K.P. Rao. ACS Omega, 2021. 6(2): p. 1657-1667. PMID[33490825]. PMCID[PMC7818581].
[PubMed]. TB_01_2021.
17. Antimycobacterial, Antioxidant and Cytotoxicity Activities of Mesoporous Nickel oxide Nanoparticles for Healthcare. Kote, J.R., A.S. Kadam, M. Ubaidullah, A.M. Al-Enizi, M.A. Al-Abdrabalnabi, A. Nafady, M. Imran, and R.S. Mane. Coatings, 2020. 10(12). ISI[000602098900001].
[WOS]. TB_01_2021.
18. Investigation of Biological Activity of 2,3-Disubstituted Quinazolin-4(1H)-ones against Mycobacterium tuberculosis and DNA via Docking, Spectroscopy and DFT Studies. Kumar, C.B.P., M.S. Raghu, K.N.N. Prasad, S. Chandrasekhar, B.K. Jayanna, F.A. Alharthi, M.K. Prashanth, and K.Y. Kumar. New Journal of Chemistry, 2021. 45(1): p. 403-414. ISI[000605477500047].
[WOS]. TB_01_2021.
19. Design, Synthesis, and Evaluation of Substituted 2-Acylamide-1,3-benzo[d]zole Analogues as Agents against MDR- and XDR-MTB. Li, D., C. Liu, X. Jiang, Y. Lin, J. Zhang, Y. Li, X. You, W. Jiang, M. Chen, Y. Xu, and S. Si. European Journal of Medicinal Chemistry, 2021. 209: 112898. PMID[33069433].
[PubMed]. TB_01_2021.
20. A Facile Synthesis and M. tuberculosis Leucyl-tRNA Synthetase Inhibitory Activity of Novel 3-Arylvinylquinoxaline-2-carboxylic acids. Li, Y., S.Y. Dong, H.W. Qin, B.Y. Tang, W.T. Gao, and Y. Chen. Chinese Journal of Organic Chemistry, 2020. 40(9): p. 2817-2826. ISI[000598058700020].
[WOS]. TB_01_2021.
21. Copper Mediated One-pot Synthesis of Quinazolinones and Exploration of Piperazine Linked Quinazoline Derivatives as Anti-mycobacterial Agents. Malasala, S., J. Gour, M.N. Ahmad, S. Gatadi, M. Shukla, G. Kaul, A. Dasgupta, Y.V. Madhavi, S. Chopra, and S. Nanduri. RSC Advances, 2020. 10(71): p. 43533-43538. ISI[000599464100033].
[WOS]. TB_01_2021.
22. Inhibiting Mycobacterium tuberculosis CoaBC by Targeting an Allosteric Site. Mendes, V., S.R. Green, J.C. Evans, J. Hess, M. Blaszczyk, C. Spry, O. Bryant, J. Cory-Wright, D.S. Chan, P.H.M. Torres, Z. Wang, N. Nahiyaan, S. O'Neill, S. Damerow, J. Post, T. Bayliss, S.L. Lynch, A.G. Coyne, P.C. Ray, C. Abell, K.Y. Rhee, H.I.M. Boshoff, C.E. Barry, 3rd, V. Mizrahi, P.G. Wyatt, and T.L. Blundell. Nature Communications, 2021. 12(1): 143. PMID[33420031]. PMCID[PMC7794376].
[PubMed]. TB_01_2021.
23. Design and Synthesis of Pyrano[3,2-b]indolones Showing Antimycobacterial Activity. Monakhova, N., J. Korduláková, A. Vocat, A. Egorova, A. Lepioshkin, E.G. Salina, J. Nosek, E. Repková, J. Zemanová, H. Jurdáková, R. Górová, J. Roh, G. Degiacomi, J.C. Sammartino, M.R. Pasca, S.T. Cole, K. Mikušová, and V. Makarov. ACS Infectious Diseases, 2021. 7(1): p. 88-100. PMID[33352041].
[PubMed]. TB_01_2021.
24. Mesoporous Silica Nanoparticles Containing Silver as Novel Antimycobacterial Agents against Mycobacterium tuberculosis. Montalvo-Quirós, S., S. Gómez-Graña, M. Vallet-Regí, R.C. Prados-Rosales, B. González, and J.L. Luque-Garcia. Colloids and Surfaces B Biointerfaces, 2021. 197: 111405. PMID[33130523].
[PubMed]. TB_01_2021.
25. Antimycobacterial, Cytotoxic, and Antioxidant Activities of Abietane Diterpenoids Isolated from Plectranthus madagascariensis. Ndjoubi, K.O., R. Sharma, J.A. Badmus, A. Jacobs, A. Jordaan, J. Marnewick, D.F. Warner, and A.A. Hussein. Plants, 2021. 10(1): 175. PMID[33477744]. PMCID[PMC7832401].
[PubMed]. TB_01_2021.
26. Design, Synthesis and Pharmacological Evaluation of Some C3 Heterocyclic-substituted Ciprofloxacin Derivatives as Chimeric Antitubercular Agents. Niveditha, N., M. Begum, D. Prathibha, K. Sirisha, P. Mahender, C. Chitra, V.R. Rao, V.M. Reddy, and G. Achaiah. Chemical & Pharmaceutical Bulletin, 2020. 68(12): p. 1170-1177. ISI[000595145900007].
[WOS]. TB_01_2021.
27. Spirocycle MmpL3 Inhibitors with Improved hERG and Cytotoxicity Profiles as Inhibitors of Mycobacterium tuberculosis Growth. Ray, P.C., M. Huggett, P.A. Turner, M. Taylor, L.A.T. Cleghorn, J. Early, A. Kumar, S.A. Bonnett, L. Flint, D. Joerss, J. Johnson, A. Korkegian, S. Mullen, A.L. Moure, S.H. Davis, D. Murugesan, M. Mathieson, N. Caldwell, C.A. Engelhart, D. Schnappinger, O. Epemolu, F. Zuccotto, J. Riley, P. Scullion, L. Stojanovski, L. Massoudi, G.T. Robertson, A.J. Lenaerts, G. Freiberg, D.J. Kempf, T. Masquelin, P.A. Hipskind, J. Odingo, K.D. Read, S.R. Green, P.G. Wyatt, and T. Parish. ACS Omega, 2021. 6(3): p. 2284-2311. PMID[33521468]. PMCID[PMC7841955].
[PubMed]. TB_01_2021.
28. Anti-tubercular Profile of New Selenium-menadione Conjugates against Mycobacterium tuberculosis H37rv (ATCC 27294) Strain and Multidrug-resistant Clinical Isolates. Ribeiro, R.C.B., D.B. de Marins, I. Di Leo, L. da Silva Gomes, M.G. de Moraes, B.L. Abbadi, A.D. Villela, W.F. da Silva, L. da Silva, P. Machado, C.V. Bizarro, L.A. Basso, M. Cristina de Moraes, V.F. Ferreira, F.C. da Silva, and V. Nascimento. European Journal of Medicinal Chemistry, 2021. 209: 112859. PMID[33010635]. PMCID[PMC7510590].
[PubMed]. TB_01_2021.
29. Discovery of a Highly Potent Novel Rifampicin Analog by Preparing a Hybrid of the Precursors of the Antibiotic Drugs Rifampicin and Clofazimine. Saravanan, P., V.N.A. Dusthackeer, R.S. Rajmani, B. Mahizhaveni, C.R. Nirmal, S.E. Rajadas, N. Bhardwaj, C. Ponnuraja, A. Bhaskar, A.K. Hemanthkumar, G. Ramachandran, and S.P. Tripathy. Scientific Reports, 2021. 11(1): 1029. PMID[33441878]. PMCID[PMC7806721].
[PubMed]. TB_01_2021.
30. Synthesis, Self-assembly, and Biological Activities of Pyrimidine-based Cationic Amphiphiles. Singh, A., S. Malhotra, D. Bimal, L.M. Bouchet, S. Wedepohl, M. Calderón, and A.K. Prasad. ACS Omega, 2021. 6(1): p. 103-112. PMID[33458463]. PMCID[PMC7807463].
[PubMed]. TB_01_2021.
31. Antitubercular 2-Pyrazolylpyrimidinones: Structure-Activity Relationship and Mode-of-action Studies. Soares de Melo, C., V. Singh, A. Myrick, S.B. Simelane, D. Taylor, C. Brunschwig, N. Lawrence, D. Schnappinger, C.A. Engelhart, A. Kumar, T. Parish, Q. Su, T.G. Myers, H.I.M. Boshoff, C.E. Barry, 3rd, F.A. Sirgel, P.D. van Helden, K.I. Buchanan, T. Bayliss, S.R. Green, P.C. Ray, P.G. Wyatt, G.S. Basarab, C.J. Eyermann, K. Chibale, and S.R. Ghorpade. Journal of Medicinal Chemistry, 2021. 64(1): p. 719-740. PMID[33395287]. PMCID[PMC7816196].
[PubMed]. TB_01_2021.
32. Synthetic Transition from Thiourea-based Compounds to Tetrazole Derivatives: Structure and Biological Evaluation of Synthesized New N-(Furan-2-ylmethyl)-1H-tetrazol-5-amine Derivatives. Szulczyk, D., A. Bielenica, P. Roszkowski, M.A. Dobrowolski, W. Olejarz, S. Kmiecik, M. Podsiad, and M. Struga. Molecules, 2021. 26(2). PMID[33435194]. PMCID[PMC7827014].
[PubMed]. TB_01_2021.
33. Phenoxyalkylimidazoles with an Oxadiazole Moiety are Subject to Efflux in Mycobacterium tuberculosis. Thayer, M.B. and T. Parish. Plos One, 2021. 16(1): e0239353. PMID[33481781]. PMCID[PMC7822546].
[PubMed]. TB_01_2021.
34. 8-Cyanobenzothiazinone Analogs with Potent Antitubercular Activity. Zhang, G., L. Sheng, P. Hegde, Y. Li, and C.C. Aldrich. Medicinal Chemistry Research. ISI[000607484900003].
[WOS]. TB_01_2021.
Patent Citations
35. Preparation of Dihydroisoxazole Compounds and Methods of Use Thereof as Antibacterial Agents. Crowley, B.M., P. Nantermet, D. Olsen, and T. Suzuki. Patent. 2021. 2020-CN93887 2021000684: 103pp.
[Patent]. TB_01_2021.
36. Preparation of Dihydroisoxazole Compounds and Methods of Use Thereof as Antibacterial Agents. Crowley, B.M., P. Nantermet, D. Olsen, and T. Suzuki. Patent. 2021. 2019-CN94601 2021000297: 60pp.
[Patent]. TB_01_2021.